A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months

Abroad (travel likely)RecruitingPHASE1

Conditions

sFlt1 Mediated Preterm Preeclampsia · Preeclampsia · Preterm Preeclampsia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Royal Women's Hospital, Parkville, Victoria, Australia
Contact: Study coordinator (Shaun Brennecke, MD) · s.brennecke@unimelb.edu.au
Monash University, Melbourne, Australia
Contact: Study coordinator (Maddie Kendall) · madeleine.kendall@monash.edu · 0456 409 087
Royal Melbourne, Melbourne, Australia
Contact: Study coordinator (Shaun Brennecke, Professor) · shaun.brennecke@thewomens.org.au · (03) 8345 3703

View source on ClinicalTrials.gov